Introduction: PRRT is an accepted treatment in Europe for patients (pts) with mNETs, but considered investigational in the USA.
Aim(s): To describe the University of Iowa (UI) experience with PRRT.
Materials and methods: One-hundred and thirty-five cases from the UI NET database were analyzed and survival calculated.
Conference: 9th Annual ENETS Conference (2012)
Presenting Author: Boris Naraev
To read results and conclusion, please login ...
Further abstracts you may be interested in